Tamsulosin 0.2mg

DRUG4 trials

Sponsors

Samsung Medical Center, IlDong Pharmaceutical Co Ltd, Chong Kun Dang Pharmaceutical, Peking University First Hospital

Conditions

Acute Urinary RetentionBenign Prostatic HyperplasiaErectile DysfunctionLUTS(Lower Urinary Tract Symptoms)

Phase 3

The Efficacy and Safety of the Combination of Tamsulosin and Tadalafil in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia and Erectile Dysfunction

IlDong Pharmaceutical Co LtdBenign Prostatic Hyperplasia, Erectile Dysfunction

Start: 2016-03-31End: 2017-03-31Target: 330Updated: 2016-08-12

Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients

CompletedNCT03246880

Chong Kun Dang PharmaceuticalBenign Prostatic Hyperplasia

Start: 2015-09-30End: 2016-05-31Updated: 2017-08-11

Phase 4

Perioperative Tamsulosin for Treating Voiding Dysfunction Following Prostate Biopsy

Not yet recruitingNCT07276919

Peking University First HospitalAcute Urinary Retention, LUTS(Lower Urinary Tract Symptoms)

Start: 2026-02-01End: 2028-01-01Target: 1844Updated: 2025-12-23

Unknown Phase

Effects of Tamsulosin 0.4mg on Clinical Outcomes in Korean Men With Severe Symptomatic Benign Prostatic Hyperplasia (BPH)

Samsung Medical CenterBenign Prostatic Hyperplasia

Start: 2011-07-31End: 2013-10-31Target: 150Updated: 2011-08-02